Satellos Bioscience (TSX:MSCL) YoY EBITDA Growth : 24.32% (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Satellos Bioscience's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 24.32%.

Satellos Bioscience's EBITDA per Share for the three months ended in Mar. 2025 was C$-0.06.

Satellos Bioscience YoY EBITDA Growth Historical Data

The historical data trend for Satellos Bioscience's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience YoY EBITDA Growth Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

-1,147.92

48.58

40.26

-32.07

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial														-85.00	-5.88	-158.06	54.10	24.32

Satellos Bioscience YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Satellos Bioscience's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.243	-	-0.184)	/	\| -0.184 \|
=	-32.07 %

Satellos Bioscience's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-0.056	-	-0.074)	/	\| -0.074 \|
=	24.32 %

Satellos Bioscience YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0ITA:Germany

Address

200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience Headlines

No Headlines